Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630].

Critical care (London, England)

Volumn 9, Issue 6, 2005, Pages

  Hoedemaekers, Cornelia W ^a   Pickkers, Peter ^a   Netea, Mihai G ^a   van Deuren, Marcel ^a   Van der Hoeven, Johannes G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BODY FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; MEDIASTINUM; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; BODY FLUIDS; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MEDIASTINUM; MIDDLE AGED; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748433074     PISSN: None     EISSN: 1466609X     Source Type: Journal    
DOI: None     Document Type: Article

References (0)